Psychiatry News and Research RSS Feed - Psychiatry News and Research

Psychiatry is the treatment, study and prevention of mental disorders.
Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Responding to rapidly shifting legal and cultural environments, researchers at the University of Montreal and CHU Sainte-Justine Children's Hospital have found a way to prevent, reduce or delay cannabis use amongst some at-risk youth. Cannabis users are at risk of neurocognitive deficits, reduced educational and occupational attainment, motor vehicle accidents, exacerbation of psychiatric symptoms, and precipitation of psychosis. [More]
Scientists reveal how disruption of DISC1 gene involved in mental illness affects the brain

Scientists reveal how disruption of DISC1 gene involved in mental illness affects the brain

Scientists have for the first time shown how the disruption of a key gene involved in mental illness impacts on the brain. [More]
Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015. [More]
Emotion regulation distinguishes unipolar and bipolar depression

Emotion regulation distinguishes unipolar and bipolar depression

Patients with bipolar disorder regulate their emotions differently from those with major depressive disorder in both depressed and remitted states, a study shows. [More]
FDA accepts Tris Pharma's Dyanavel XR NDA for review

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Tris Pharma, Inc. announced that U.S. Food and Drug Administration has accepted for review its New Drug Application ("NDA") for Dyanavel XR (amphetamine) CII, an Extended-Release Oral Suspension. [More]
HQO report shows variations across Ontario's long-term care homes regarding antipsychotic drug use

HQO report shows variations across Ontario's long-term care homes regarding antipsychotic drug use

There are major differences across Ontario's long-term care homes in the percentage of residents who are being prescribed antipsychotic medications, according to Looking for Balance, a report from Health Quality Ontario, the provincial advisor on health care quality. [More]
Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Teens with slower performance on a test of "cognitive processing speed" are more likely to have depression and anxiety symptoms as adults, reports a paper in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. [More]
New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

A new study by UCLA researchers has found that Naltrexone, a drug used to treat alcoholism, may also be a promising treatment for addiction to methamphetamine. [More]
Study: Air pollution, impaired lung function independently affect cognition

Study: Air pollution, impaired lung function independently affect cognition

Studies have shown that both air pollution and impaired lung function can cause cognitive deficits, but it was unclear whether air pollution diminishes cognition by reducing breathing ability first or whether air pollution represents an independent risk factor for cognitive deficit. [More]
Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries. [More]
APS announces recipients of prestigious achievement awards during annual scientific meeting

APS announces recipients of prestigious achievement awards during annual scientific meeting

The American Pain Society (APS), www.americanpainsociety.org, today announced the recipients of its prestigious achievement awards during the organization's annual scientific meeting. [More]
Workplace mindfulness-based intervention reduces stress levels of employees

Workplace mindfulness-based intervention reduces stress levels of employees

A study by researchers at The Ohio State University Wexner Medical Center found that a workplace mindfulness-based intervention reduced stress levels of employees exposed to a highly stressful occupational environment. [More]
New work challenges long-held beliefs about link between hippocampus and improved memory function

New work challenges long-held beliefs about link between hippocampus and improved memory function

New work by the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-MontréalI) computational neuroscientist Mallar Chakravarty, PhD, and in collaboration with researchers at the Centre for Addiction and Mental Health challenges in a thrilling way the long-held belief that a larger hippocampus is directly linked to improved memory function. [More]
Serotonin and TGF-beta pathways link diet to health and ageing

Serotonin and TGF-beta pathways link diet to health and ageing

Diet exerts a major impact on health and ageing. The nervous system plays an important role in this process but, thus far, how food signals are interpreted by the nervous system has been a mystery. [More]
Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Secondhand exposure to cannabis smoke under "extreme conditions," such as an unventilated room or enclosed vehicle, can cause nonsmokers to feel the effects of the drug, have minor problems with memory and coordination, and in some cases test positive for the drug in a urinalysis. [More]
Transgender people at greater risk for eating disorders

Transgender people at greater risk for eating disorders

Transgender and non-transgender lesbian, gay and bisexual students are at greater risk for eating disorders, finds a new study from the Brown School at Washington University in St. Louis and Washington University School of Medicine in St. Louis. [More]
UBM Medica recognized with three national accolades by ASHPE

UBM Medica recognized with three national accolades by ASHPE

UBM Medica announced today that Physicians Practice, a leading online community for physicians and practice management professionals, has been recognized by the American Society of Healthcare Publication Editors with three national accolades. [More]
Catatonia may cause regression in Down syndrome patients

Catatonia may cause regression in Down syndrome patients

Down syndrome, the most common chromosomal disorder in America, can be complicated by significant deterioration in movement, speech and functioning in some adolescents and young adults. Physicians previously attributed this regression to depression or early-onset Alzheimer's, and it has not responded to treatments. [More]
Cardiome signs commercialization agreement with AOP for ESMOCARD products

Cardiome signs commercialization agreement with AOP for ESMOCARD products

Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium. [More]
Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Extremely high levels of cardiovascular risk factors have been found in people with established psychosis, with central obesity evident in over 80 per cent of participants, in a study by researchers from the NIHR Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London. [More]
Advertisement